当前位置: 首页 > 新闻资讯 > 产品文献 > "酶免"产品文献：Upregulation of Superenhancer-Driven LncRNA FASRL by USF1 Promotes De Novo Fatty Acid Biosynthesis to Exacerbate Hepatocellular Carcinoma

"酶免"产品文献：Upregulation of Superenhancer-Driven LncRNA FASRL by USF1 Promotes De Novo Fatty Acid Biosynthesis to Exacerbate Hepatocellular Carcinoma

酶免官方商城 / 2023-12-29

文献标题

Upregulation of Superenhancer-Driven LncRNA FASRL by USF1 Promotes De Novo Fatty Acid Biosynthesis to Exacerbate Hepatocellular Carcinoma

文献作者

Jiang-Yun Peng、Dian-Kui Cai、Ren-Li Zeng、Chao-Yang Zhang、Guan-Cheng Li、Si-Fan Chen、Xiao-Qing Yuan、Li Peng

发表时间

2022年10月28日

文献影响因子

17.521

使用的酶免科研试剂盒产品名称

人丙二酰辅酶A（malonyl CoA）ELISA科研试剂盒

人流感H3N2抗体IgM（H3N2- IgM）ELISA科研试剂盒

人类白C抗原DRA4（HLA-DRA4）ELISA科研试剂盒

下一篇:"酶免"产品文献：Role of nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 6 in activation of inflammation in human umbilical vein endothelial cells stimulated by Porphyromonas gingivalis-an in vitro study
上一篇:"酶免"产品文献：Efficient Targeted Delivery of Bifunctional Circular Aptamer-ASO Chimera to Suppress the SARS-CoV-2 Proliferation and Inflammation

全部产品分类

浏览历史

"酶免"产品文献：Upregulation of Superenhancer-Driven LncRNA FASRL by USF1 Promotes De Novo Fatty Acid Biosynthesis to Exacerbate Hepatocellular Carcinoma